OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
🇺🇸United States
Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-08-29
- Last Posted Date
- 2019-05-15
- Target Recruit Count
- 511
- Registration Number
- NCT01424670
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-08-26
- Last Posted Date
- 2015-10-29
- Target Recruit Count
- 218
- Registration Number
- NCT01423916
- Locations
- 🇺🇸
Otsuka Investigational Site, Austin, Texas, United States
Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer
- First Posted Date
- 2011-08-26
- Last Posted Date
- 2014-01-15
- Target Recruit Count
- 45
- Registration Number
- NCT01423903
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
- First Posted Date
- 2011-08-17
- Last Posted Date
- 2021-10-07
- Target Recruit Count
- 83
- Registration Number
- NCT01418352
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- First Posted Date
- 2011-08-17
- Last Posted Date
- 2021-10-07
- Target Recruit Count
- 135
- Registration Number
- NCT01418339
Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2021-10-07
- Target Recruit Count
- 170
- Registration Number
- NCT01416441
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2017-05-10
- Target Recruit Count
- 1044
- Registration Number
- NCT01397786
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-07-18
- Last Posted Date
- 2015-10-29
- Target Recruit Count
- 636
- Registration Number
- NCT01396421
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
- First Posted Date
- 2011-07-15
- Last Posted Date
- 2016-04-08
- Target Recruit Count
- 202
- Registration Number
- NCT01395017
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2015-11-26
- Target Recruit Count
- 674
- Registration Number
- NCT01393613
© Copyright 2024. All Rights Reserved by MedPath